Brain Stimulation for Memory Loss
(NACC-EC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if combining accelerated deep Transcranial Magnetic Stimulation (dTMS) with cognitive training can improve memory and thinking skills in older adults with memory issues. Participants will receive either real dTMS or a sham version (placebo-like) and will engage in online cognitive exercises. The trial targets individuals aged 55-85 who are concerned about their memory and maintain a stable medication routine. Researchers will assess the safety and tolerability of this approach while collecting early data on its effects on memory. As an unphased trial, this study allows participants to contribute to innovative research that could enhance memory care for older adults.
Will I have to stop taking my current medications?
You need to be stable on your medications for at least 2 months before joining the study and should not expect to change them during the study. If you are on unstable doses of certain medications like antidepressants or memory enhancers, you may not be eligible.
What prior data suggests that this protocol is safe for older adults with cognitive decline?
Research has shown that accelerated deep Transcranial Magnetic Stimulation (dTMS) is generally safe and well-tolerated. Studies on people with depression found that these faster treatments are as safe as the standard once-a-day sessions, with no major safety issues reported.
Previous research used dTMS for conditions like Parkinson's and Alzheimer's diseases, indicating a good safety record. Accelerated dTMS targets deeper brain areas, potentially improving memory and thinking skills.
Overall, this treatment has demonstrated safety in other situations, and similar methods have been used without serious side effects.12345Why are researchers excited about this trial?
Researchers are excited about the treatment for memory loss because it involves an innovative approach called accelerated neuromodulation of the anterior cingulate cortex. Unlike most treatments that rely on medications, this method uses targeted brain stimulation, specifically intermittent theta-burst stimulation (iTBS). This technique is believed to directly enhance neural pathways associated with memory, potentially offering quicker and more precise improvements in cognitive function. Additionally, combining this with online cognitive remediation could further boost memory performance, offering a holistic approach to managing memory loss.
What evidence suggests that this trial's treatments could be effective for memory loss?
Research has shown that deep Transcranial Magnetic Stimulation (dTMS) can improve memory by targeting specific brain areas. In this trial, participants will receive either accelerated dTMS combined with mental exercises or sham stimulation with mental exercises. In accelerated dTMS, patients experienced better thinking skills when combined with mental exercises. This method uses magnetic fields to gently stimulate the brain, potentially enhancing memory and thinking. Although still under study, early research suggests this technique could help older adults with memory issues.12678
Who Is on the Research Team?
Linda Mah, MD
Principal Investigator
Baycrest Rotman Research Institute
Are You a Good Fit for This Trial?
This trial is for older adults aged 55-85 with mild memory problems or Mild Cognitive Impairment, scoring at least 24 on the MMSE. Participants must be stable on medications, able to consent and follow the treatment schedule. Exclusions include metal in the head, unstable medical conditions, contraindications to TMS like pacemakers, certain psychiatric disorders or substance abuse history.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 20-40 sessions of dTMS or sham stimulation over 2-5 consecutive days, followed by 6 weeks of online cognitive remediation
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Accelerated Neuromodulation of Anterior Cingulate Cortex
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rotman Research Institute at Baycrest
Lead Sponsor